Barry Schweitzer

Nessuna posizione attualmente

Consumer Services

Health Technology

Finance

Profilo

Barry Schweitzer served as the Chief Executive Officer at GlyGenix Therapeutics, Inc. from 2015 to 2017.
Prior to that, he worked as a Venture Partner at Elm Street Advisors LLC.
Schweitzer received his undergraduate degree from Dartmouth College and his doctorate from Yale University.

Precedenti posizioni note di Barry Schweitzer

Società	Posizione	Fine
GlyGenix Therapeutics, Inc. GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT.	Amministratore Delegato	01/01/2017
Elm Street Advisors LLC Elm Street Advisors LLC Investment ManagersFinance Elm Street Advisors LLC (Elm Street Ventures) is a venture capital firm founded in 2006 by Robert A. Bettigole. The firm is headquartered in New Haven, Connecticut.	Investitore di Private Equity	-

Vedi nel dettaglio l'esperienza di Barry Schweitzer

Formazione di Barry Schweitzer

Dartmouth College	Undergraduate Degree
Yale University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private